Paysign, Inc. is a financial technology company that provides prepaid card programs, digital banking services, and integrated payment processing solutions primarily for the healthcare, pharmaceutical, and life sciences industries in the United States. The company operates a proprietary, vertically integrated payments platform that allows it to manage the entire prepaid card lifecycle in-house, including transaction processing, cardholder enrollment, value loading, account management, and customer service.
Paysign's revenue is primarily driven by two core segments: plasma donor compensation and pharmaceutical patient affordability programs. In the plasma donation sector, the company provides prepaid debit cards used by collection centers to compensate donors, replacing traditional cash or check payments. In the pharmaceutical space, Paysign offers copay assistance and affordability solutions that help patients access prescribed therapies by mitigating out-of-pocket costs. The company also provides corporate rewards, employee incentives, general-purpose reloadable debit cards, and disbursement solutions for various other industries, including retail and hospitality.
Revenue is generated through a combination of cardholder fees, interchange fees, program management fees, and transaction claims processing fees. By focusing heavily on the specialized needs of the healthcare sector, Paysign has established a strong competitive position, leveraging its dynamic business rules technology to optimize copay assistance programs and deliver measurable value to pharmaceutical manufacturers, healthcare providers, and patients.
